UTAH MEDICAL PRODUCTS, INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2020-03-16
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2017-12-31 was -$4.99K, a 349.33% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2017-09-30 was $2.00K, a 0.00% change year-over-year.
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2017-06-30 was $3.00K.
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2017-03-31 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2019 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2017 was $6.00, a 100.00% increase from fiscal 2016.
- UTAH MEDICAL PRODUCTS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2016 was $3.00.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-16 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 | ||||
| 2017-12-31 | -$4.99K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$2.99K derived: sum of 2 quarters · filed 2020-03-16 | $6.00 derived: sum of 3 quarters · filed 2020-03-16 | $6.00 10-K · filed 2020-03-16 | $6.00K 10-K · filed 2018-03-06 |
| 2017-09-30 | $2.00K 10-Q · filed 2017-11-07 | $5.00K derived: sum of 2 quarters · filed 2017-11-07 | $5.00K 10-Q · filed 2017-11-07 | $7.00K derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | $3.00K 10-Q · filed 2017-08-03 | $3.00K 10-Q · filed 2017-08-03 | $5.00K derived: sum of 3 quarters · filed 2019-03-14 | $7.00K derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-05 | $2.00K derived: sum of 2 quarters · filed 2019-03-14 | $4.00K derived: sum of 3 quarters · filed 2019-03-14 | $4.00K derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $4.00K derived: sum of 2 quarters · filed 2019-03-14 | $4.00K derived: sum of 3 quarters · filed 2019-03-14 | $3.00 10-K · filed 2019-03-14 | $3.00K 10-K · filed 2017-03-08 |
| 2016-09-30 | $2.00K 10-Q · filed 2017-11-07 | $2.00K derived: sum of 2 quarters · filed 2017-11-07 | -$2.00K 10-Q · filed 2017-11-07 | -$1.00K derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | -$4.00K 10-Q · filed 2017-08-03 | -$3.00K derived: sum of 3 quarters · filed 2018-03-06 | -$5.00K derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-03-31 | -$4.00K 10-Q · filed 2017-05-05 | -$3.00K derived: sum of 2 quarters · filed 2018-03-06 | -$5.00K derived: sum of 3 quarters · filed 2018-03-06 | -$3.00K derived: sum of 4 quarters · filed 2018-03-06 | |
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$1.00K derived: sum of 2 quarters · filed 2018-03-06 | $1.00K derived: sum of 3 quarters · filed 2018-03-06 | -$1.00K 10-K · filed 2018-03-06 | |
| 2015-09-30 | -$2.00K 10-Q · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | -$2.00K 10-Q · filed 2016-11-04 | $0.00 derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-06-30 | $2.00K 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $2.00K derived: sum of 3 quarters · filed 2017-03-08 | $4.00K derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-03-31 | -$1.00K 10-Q · filed 2016-05-06 | $0.00 derived: sum of 2 quarters · filed 2017-03-08 | $2.00K derived: sum of 3 quarters · filed 2017-03-08 | $2.00K derived: sum of 4 quarters · filed 2017-03-08 | |
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $3.00K derived: sum of 2 quarters · filed 2017-03-08 | $3.00K derived: sum of 3 quarters · filed 2017-03-08 | $1.00K 10-K · filed 2017-03-08 | |
| 2014-09-30 | $2.00K 10-Q · filed 2015-11-06 | $2.00K derived: sum of 2 quarters · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | $2.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-07 | -$2.00K 10-Q · filed 2015-08-07 | $0.00 derived: sum of 3 quarters · filed 2016-03-10 | $0.00 derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-03-31 | -$2.00K 10-Q · filed 2015-05-06 | $0.00 derived: sum of 2 quarters · filed 2016-03-10 | $0.00 derived: sum of 3 quarters · filed 2016-03-10 | $2.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2013-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $2.00K derived: sum of 2 quarters · filed 2016-03-10 | $4.00K derived: sum of 3 quarters · filed 2016-03-10 | $6.00K 10-K · filed 2016-03-10 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-04 | $2.00K derived: sum of 2 quarters · filed 2014-11-04 | $4.00K 10-Q · filed 2014-11-04 | $121.00K derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $2.00K 10-Q · filed 2014-08-08 | $4.00K 10-Q · filed 2014-08-08 | $121.00K derived: sum of 3 quarters · filed 2015-03-12 | $125.00K derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $2.00K 10-Q · filed 2014-05-07 | $119.00K derived: sum of 2 quarters · filed 2015-03-12 | $123.00K derived: sum of 3 quarters · filed 2015-03-12 | $120.00K derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $121.00K derived: sum of 2 quarters · filed 2015-03-12 | $118.00K derived: sum of 3 quarters · filed 2015-03-12 | $123.00K 10-K · filed 2015-03-12 | |
| 2012-09-30 | $4.00K 10-Q · filed 2013-11-06 | $1.00K derived: sum of 2 quarters · filed 2013-11-06 | $6.00K 10-Q · filed 2013-11-06 | ||
| 2012-06-30 | -$3.00K 10-Q · filed 2013-08-08 | $3.00K 10-Q · filed 2013-08-08 | |||
| 2012-03-31 | $6.00K 10-Q · filed 2013-05-08 | ||||
| 2011-12-31 | -$2.00K 10-K · filed 2014-03-12 | ||||
| 2010-12-31 | $29.00K 10-K · filed 2013-03-07 | ||||
| 2009-12-31 | $10.00K 10-K/A · filed 2012-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |